ArticleBiomechanics and modeling in mechanobiology2026
Baseline state for pulmonary vasculature with pulmonary arterial hypertension: effect of geometric remodeling and metabolic shift.
Article in Biomechanics and modeling in mechanobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Pulmonary arterial hypertension (PAH) is a complex disease characterized by chronically elevated pulmonary arterial pressure, with early onset and progression linked to structural, metabolic, and morphological changes in the pulmonary vasculature. Understanding the interplay between hemodynamics and arterial wall mechanics is essential to capture the pathology of the distal vasculature in PAH. This study aims to develop a data-driven framework that establishes a baseline state of PAH vasculature, incorporating key features of arterial wall constituents, geometry, and their interaction with PAH-specific hemodynamics. Illustrative examples of symmetrically bifurcating arterial trees are used to define representative baseline characteristics of PAH-affected pulmonary arteries. Compared with healthy homeostatic vasculature, the computational results demonstrate pronounced geometric and mechanical alterations: Arterial stiffness increases from approximately 7-10 kPa in healthy arteries to 300-800 kPa in PAH, representing a ~ 40-85 times increase across generations. Because wall thickening is imposed from histological measurements while outer diameter is preserved, the diameter-to-thickness ratio (D/h) decreases from ~ 14 in healthy arteries to ~ 3.8 in PAH, reflecting severe lumen narrowing and medial hypertrophy. In addition, the metabolic energy cost per unit length in PAH is more than double that of healthy arteries when assuming unchanged metabolic consumption per unit volume, whereas enforcing equal total energy cost yields a reduced per-volume metabolic consumption of ~ 450-500 W/m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.